We are live on
!
Find out more
OR
Olympiad Research Portfolio holdings
AUM
$32.8M
1-Year Est. Return
50.11%
This Fund
S&P 500
This Quarter
Est. Return
+5.74%
1 Year Est. Return
+50.11%
3 Year Est. Return
+116.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
+$17.8M
(+13%)
Cap. Flow
+$14.3M
Cap. Flow
% of AUM
9.32%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
503
New
162
Increased
64
Reduced
67
Closed
185
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRDX
Surmodics
SRDX
|
+$1.97M |
| 2 |
TELL
Tellurian Inc.
TELL
|
+$1.78M |
| 3 |
K
Kellanova
K
|
+$1.77M |
| 4 |
Bally's
BALY
|
+$1.58M |
| 5 |
EVRI
Everi Holdings
EVRI
|
+$1.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$2.14M |
| 2 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$2.08M |
| 3 |
McGrath RentCorp
MGRC
|
+$1.71M |
| 4 |
SRCL
Stericycle Inc
SRCL
|
+$1.48M |
| 5 |
MCBC
Macatawa Bank Corp
MCBC
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.55% |
| 2 | Consumer Discretionary | 16.26% |
| 3 | Industrials | 13.1% |
| 4 | Energy | 10.97% |
| 5 | Financials | 8.25% |
Similar funds
SCA
RL
PE
MP
SP
QCA
WTG
VL
Olympiad Research's Q3 2024 Portfolio in Review
As of Q3 2024, Olympiad Research held 503 positions worth $154M, up 13% from $136M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Olympiad Research deployed $14.3M of net new capital in Q3 2024, opening 162 new positions and adding to 64 existing holdings. Its largest new stake was Surmodics: 48,591 shares worth $1.88M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clear Secure, an estimated $375K trimmed.
- Olympiad Research's largest Q3 2024 buy was Surmodics: 48,591 shares worth $1.88M.
- Olympiad Research added most to Bally's in Q3 2024, an estimated $1.58M increase.
- Olympiad Research's biggest Q3 2024 reduction was Clear Secure, cutting an estimated $375K.
- Olympiad Research fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $2.14M.
- Olympiad Research's ten largest holdings make up 14% of its $154M portfolio in Q3 2024.
- Olympiad Research opened 162 new positions and closed 185 in Q3 2024.
- Olympiad Research's portfolio value rose 13% quarter-over-quarter to $154M.
Based on Olympiad Research's 13F filing for Q3 2024, filed 31 Oct 2024.